Cases 1 - 5 of 5
In re: Leatha Taylor, et al v. Bristol-Myers Squibb Company, et al
as 22-6078
Not Classified By Court:
In re: ONGLYZA (SAXAGLIPTIN) AND KOMBIGLYZE (SAXAGLIPTIN AND METFORMIN) PRODUCTS LIABILITY LITIGATION MDL 2809
Plaintiff / Appellant:
LEATHA TAYLOR, Individually and as Administratrix of Estate of David Taylor, KATHY BARNES, LISA ARLENE PEOPLES and others
Defendant / Appellee:
BRISTOL-MYERS SQUIBB COMPANY, ASTRAZENECA PHARMACEUTICALS LP, IPR PHARMACEUTICALS INC. and others
Taylor et al v. Bristol-Myers Squibb Company, Inc. et al
as 5:2018cv00053
Plaintiff:
David Taylor and Leatha Taylor
Defendant:
Bristol-Myers Squibb Company, Inc. and AstraZeneca Pharmaceuticals LP
Cause Of Action: 28 U.S.C. § 1332
In re: Onglyza (Saxagliptin) and Kombiglyze (Saxagliptin and Metformin) Products Liability Litigation MDL 2809
as 5:2018md02809
Defendant:
Onglyza (Saxagliptin) and Kombiglyze (Saxagliton and Metformin) Products Liability Litigation MDL 2809, McKesson Corporation, Bristol-Myers Squibb Company, Inc. and others
Plaintiff:
Susan Settle, Charles David Ware, William Dinger Sr. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Taylor et al v. Bristol-Myers Squibb Company, Inc. et al
as KYE/5:16-cv-00260
Plaintiff:
David Taylor and Leatha Taylor
Defendant:
Bristol-Myers Squibb Company, Inc. and AstraZeneca Pharmaceuticals LP
Taylor et al v. Bristol-Myers Squibb Company, Inc. et al
as 5:2016cv00260
Plaintiff:
David Taylor and Leatha Taylor
Defendant:
Bristol-Myers Squibb Company, Inc., Aztrazeneca Pharmaceuticals LP, IPR Pharmaceuticals, Inc. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
